116 related articles for article (PubMed ID: 26689452)
1. Cell-Permeable Esterase-Activated Ca(II)-Sensitive MRI Contrast Agent.
MacRenaris KW; Ma Z; Krueger RL; Carney CE; Meade TJ
Bioconjug Chem; 2016 Feb; 27(2):465-73. PubMed ID: 26689452
[TBL] [Abstract][Full Text] [Related]
2. An esterase-activated magnetic resonance contrast agent.
Giardiello M; Lowe MP; Botta M
Chem Commun (Camb); 2007 Oct; (39):4044-6. PubMed ID: 17912410
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging with a cell-permeable porphyrin-based MRI contrast agent.
Lee T; Zhang XA; Dhar S; Faas H; Lippard SJ; Jasanoff A
Chem Biol; 2010 Jun; 17(6):665-73. PubMed ID: 20609416
[TBL] [Abstract][Full Text] [Related]
4. Indirectly probing Ca(2+) handling alterations following myocardial infarction in a murine model using T(1)-mapping manganese-enhanced magnetic resonance imaging.
Waghorn B; Schumacher A; Liu J; Jacobs S; Baba A; Matsuda T; Yanasak N; Hu TC
Magn Reson Med; 2011 Jan; 65(1):239-49. PubMed ID: 20872864
[TBL] [Abstract][Full Text] [Related]
5. New calcium-selective smart contrast agents for magnetic resonance imaging.
Verma KD; Forgács A; Uh H; Beyerlein M; Maier ME; Petoud S; Botta M; Logothetis NK
Chemistry; 2013 Dec; 19(52):18011-26. PubMed ID: 24353083
[TBL] [Abstract][Full Text] [Related]
6. A Multimodal Ca(II) Responsive Near IR-MR Contrast Agent Exhibiting High Cellular Uptake.
Adams CJ; Krueger R; Meade TJ
ACS Chem Biol; 2020 Feb; 15(2):334-341. PubMed ID: 31967770
[TBL] [Abstract][Full Text] [Related]
7. Membrane permeable esterase-activated fluorescent imaging probe.
Kim Y; Choi Y; Weissleder R; Tung CH
Bioorg Med Chem Lett; 2007 Sep; 17(18):5054-7. PubMed ID: 17664067
[TBL] [Abstract][Full Text] [Related]
8. Monitoring dynamic alterations in calcium homeostasis by T1-mapping manganese-enhanced MRI (MEMRI) in the early stage of small intestinal ischemia-reperfusion injury.
Zhao DW; Zhang LT; Cheng HY; Zhang YL; Min JY; Xiao HL; Wang Y
NMR Biomed; 2015 Aug; 28(8):958-66. PubMed ID: 26086648
[TBL] [Abstract][Full Text] [Related]
9. MR contrast agent composed of cholesterol and peptide nucleic acids: design, synthesis and cellular uptake.
Joshi R; Mishra R; Pohmann R; Engelmann J
Bioorg Med Chem Lett; 2010 Apr; 20(7):2238-41. PubMed ID: 20189384
[TBL] [Abstract][Full Text] [Related]
10. Calcium-dependent molecular fMRI using a magnetic nanosensor.
Okada S; Bartelle BB; Li N; Breton-Provencher V; Lee JJ; Rodriguez E; Melican J; Sur M; Jasanoff A
Nat Nanotechnol; 2018 Jun; 13(6):473-477. PubMed ID: 29713073
[TBL] [Abstract][Full Text] [Related]
11. Membrane-Permeable Mn(III) Complexes for Molecular Magnetic Resonance Imaging of Intracellular Targets.
Barandov A; Bartelle BB; Gonzalez BA; White WL; Lippard SJ; Jasanoff A
J Am Chem Soc; 2016 May; 138(17):5483-6. PubMed ID: 27088782
[TBL] [Abstract][Full Text] [Related]
12. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
13. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents.
Patel D; Kell A; Simard B; Xiang B; Lin HY; Tian G
Biomaterials; 2011 Feb; 32(4):1167-76. PubMed ID: 21035183
[TBL] [Abstract][Full Text] [Related]
14. Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 Tesla.
Loai Y; Sakib N; Janik R; Foltz WD; Cheng HL
Mol Imaging; 2012 Apr; 11(2):166-75. PubMed ID: 22469244
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of a cell-permeable bimodal contrast agent targeting β-galactosidase.
Keliris A; Ziegler T; Mishra R; Pohmann R; Sauer MG; Ugurbil K; Engelmann J
Bioorg Med Chem; 2011 Apr; 19(8):2529-40. PubMed ID: 21459584
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
17. Sensing intracellular calcium ions using a manganese-based MRI contrast agent.
Barandov A; Bartelle BB; Williamson CG; Loucks ES; Lippard SJ; Jasanoff A
Nat Commun; 2019 Feb; 10(1):897. PubMed ID: 30796208
[TBL] [Abstract][Full Text] [Related]
18. Calcium accumulation in synapses of the rat hippocampus after cerebral ischemia.
Gajkowska B; Mossakowski MJ
Neuropatol Pol; 1992; 30(2):111-25. PubMed ID: 1297926
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
20. Relationship of cytosolic ion fluxes and protein kinase C activation to platelet-derived growth factor induced competence and growth in BALB/c-3T3 cells.
Zagari M; Stephens M; Earp HS; Herman B
J Cell Physiol; 1989 Apr; 139(1):167-74. PubMed ID: 2708452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
